Transcatheter Valve Repair System Market

Transcatheter Valve Repair System Market (Product: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Transcatheter Valve Repair System Market Outlook 2031

  • The global industry was valued at US$ 4.7 Bn in 2022
  • It is projected to grow at a CAGR of 7.7% from 2023 to 2031 and reach more than US$ 9.1 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

Rise in demand for minimally invasive treatments for valve diseases and increase in aging population are fueling the transcatheter valve repair system market dynamics. Transcatheter valve repair system is used to repair damaged or diseased heart valves without the need for open-heart surgery.

Growth in awareness about the benefits of minimally invasive procedures, advancements in technology, and the development of new and more efficient transcatheter valve repair systems are projected to augment market expansion in the near future. However, high cost of transcatheter valve repair procedures, shortage of trained healthcare professionals, and regulatory barriers to market entry are some of the key challenges facing the industry.

Transcatheter Valve Repair System Market

Market Introduction

Transcatheter valve repair systems are minimally invasive devices designed for the treatment of heart valve diseases, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation, without the need for open-heart surgery.

The transcatheter valve repair procedure is performed by inserting a catheter through a small incision in the leg or chest and guiding it to the heart using imaging guidance. A transcatheter valve repair device is then deployed through the catheter and positioned over the damaged heart valve. The device either repairs the valve or replaces it with a new one.

Rise in Prevalence of Chronic Heart Diseases Boosting Transcatheter Valve Repair System Market Size

Heart valve disease is a condition in which the heart valves do not function properly, leading to a range of symptoms and complications. According to the World Health Organization (WHO), heart valve disease is a leading cause of death and disability worldwide. The disease impacts more than 5 million people in the U.S. Thus, high incidence of heart diseases is estimated to spur transcatheter valve repair system industry growth in the near future.

Increase in Investment in R&D of New Products

Transcatheter valve repair system offers several advantages, such as lesser pain, shorter hospital stay, faster recovery time, and a reduced risk of complications, over traditional open-heart surgery. Companies operating in the business are developing advanced products to increase their transcatheter valve repair system market share.

Development of self-expanding transcatheter valves offers several benefits over traditional balloon-expandable valves. These include better hemodynamic performance, lower risk of paravalvular leak, and improved patient outcomes.

Novel transcatheter valve repair systems are being designed with improved functionality and durability, making them more efficient and effective. New valve designs feature enhanced leaflets and stents that reduce the risk of structural valve deterioration, thus ensuring long-term efficacy. These advancements have boosted the adoption of transcatheter valve repair systems across the globe.

According to a report by the Society of Thoracic Surgeons, the number of TAVR procedures performed globally increased from approximately 15,000 in 2012 to more than 200,000 in 2020. Thus, rise in investment in R&D of new products is expected to drive the transcatheter valve repair system market value in the next few years.

High Adoption of Transcatheter Aortic Valve Replacement (TAVR)

According to the latest transcatheter valve repair system market analysis, the Transcatheter Aortic Valve Replacement (TAVR) product segment held major share in 2022. TAVR is a medical device employed for the treatment of damaged or diseased heart valves without the need for open-heart surgery.

Rise in prevalence of aortic stenosis, growth in demand for minimally invasive valve repair procedures, and presence of favorable reimbursement policies for TAVR procedures in several countries are some of the key factors boosting the segment.

Growth in Incidence of Aortic Stenosis

According to the latest transcatheter valve repair system market trends, the aortic stenosis application segment is expected to account for significant share during the forecast period.

Aortic stenosis is a medical condition in which the aortic valve in the heart becomes narrowed, thus reducing blood flow to the rest of the body. This condition can be caused by aging, genetics, or certain health conditions such as high blood pressure and heart disease.

Regional Outlook

North America accounted for the largest market share of around 40.0% in 2022. The region is anticipated to maintain its dominance from 2023 to 2031, according to the latest transcatheter valve repair system market forecast. Increase in incidence of heart diseases, presence of major vendors, and rise in investment in R&D activities are boosting market statistics in the region.

The industry in Asia Pacific is projected to grow at the fastest pace during the forecast period due to high incidence of cardiovascular diseases and surge in geriatric population.

Analysis of Key Players in Transcatheter Valve Repair System Market

The global business is fragmented, with the presence of a large number of vendors. Prominent manufacturers are developing advanced minimally invasive delivery systems that make transcatheter valve repair procedures safer and more precise. These systems include catheters with advanced imaging capabilities and improved navigation systems, which make it easier for physicians to accurately place the valve.

Abbott Laboratories, Biotronik Pvt. Ltd., Colibri Heart Valve, Edwards Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic plc, Neovasc Inc., and Coramaze Technologies are key entities operating in this market.

These players have been profiled in the transcatheter valve repair system market report based on parameters such as company overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In December 2022, Abbott launched Navitor, its latest-generation TAVI system for the treatment of severe aortic stenosis, in India
  • In September 2022, Medtronic announced the expanded release of Evolut FX TAVR, its newest-generation, self-expanding TAVR system, in the U.S.

Global Transcatheter Valve Repair System Market Snapshot

Attribute

Detail

Market Size Value in 2022

US$ 4.7 Bn

Market Forecast Value in 2031

More than US$ 9.1 Bn

Growth Rate (CAGR)

7.7%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Transcatheter Aortic Valve Replacement (TAVR)
    • Transcatheter Mitral Valve Replacement (TMVR)
    • Transcatheter Pulmonary Valve Replacement (TPVR)
    • Transcatheter Tricuspid Valve Replacement (TTVR)
  • Application
    • Aortic Stenosis
    • Mitral Stenosis
    • Tricuspid Stenosis
    • Pulmonary Stenosis
  • End-user
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Abbott Laboratories
  • Biotronik Pvt. Ltd.
  • Colibri Heart Valve
  • Edwards Lifesciences Corporation
  • HLT Medical
  • LivaNova Plc
  • Medtronic plc
  • Neovasc Inc
  • Coramaze Technologies

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global transcatheter valve repair system market in 2022?

It was valued at US$ 4.7 Bn in 2022.

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 7.7% from 2023 to 2031.

How big will the industry be by 2031?

It is projected to reach more than US$ 9.1 Bn by the end of 2031.

Which are the prominent trends that affect business growth?

Rise in prevalence of chronic heart diseases and increase in investment in R&D of new products.

Which region is expected to account for major share during the forecast period?

North America is projected to account for major share from 2023 to 2031.

Who are the prominent players operating in the sector?

Abbott Laboratories, Biotronik Pvt. Ltd, Colibri Heart Valve, Edwards Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic plc, Neovasc Inc., and Coramaze Technologies.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transcatheter Valve Repair System Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Transcatheter Valve Repair System Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Pricing Analysis

    5.3. Key Product/Brand Analysis

    5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Transcatheter Valve Repair System Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value & Volume Forecast, by Product, 2017–2031

        6.3.1. Transcatheter Aortic Valve Replacement (TAVR)

        6.3.2. Transcatheter Mitral Valve Replacement (TMVR)

        6.3.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        6.3.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    6.4. Market Attractiveness Analysis, by Product

7. Global Transcatheter Valve Repair System Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Aortic Stenosis

        7.3.2. Mitral Stenosis

        7.3.3. Tricuspid Stenosis

        7.3.4. Pulmonary Stenosis

    7.4. Market Attractiveness Analysis, by Application

8. Global Transcatheter Valve Repair System Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Specialty Clinics

        8.3.3. Ambulatory Surgical Centers

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Transcatheter Valve Repair System Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Transcatheter Valve Repair System Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Product, 2017–2031

        10.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        10.2.2. Transcatheter Mitral Valve Replacement (TMVR)

        10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        10.2.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Aortic Stenosis

        10.3.2. Mitral Stenosis

        10.3.3. Tricuspid Stenosis

        10.3.4. Pulmonary Stenosis

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Specialty Clinics

        10.4.3. Ambulatory Surgical Centers

        10.4.4. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Transcatheter Valve Repair System Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Product, 2017–2031

        11.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        11.2.2. Transcatheter Mitral Valve Replacement (TMVR)

        11.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        11.2.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Aortic Stenosis

        11.3.2. Mitral Stenosis

        11.3.3. Tricuspid Stenosis

        11.3.4. Pulmonary Stenosis

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Specialty Clinics

        11.4.3. Ambulatory Surgical Centers

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Transcatheter Valve Repair System Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Product, 2017–2031

        12.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        12.2.2. Transcatheter Mitral Valve Replacement (TMVR)

        12.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        12.2.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Aortic Stenosis

        12.3.2. Mitral Stenosis

        12.3.3. Tricuspid Stenosis

        12.3.4. Pulmonary Stenosis

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Specialty Clinics

        12.4.3. Ambulatory Surgical Centers

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Transcatheter Valve Repair System Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Product, 2017–2031

        13.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        13.2.2. Transcatheter Mitral Valve Replacement (TMVR)

        13.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        13.2.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Aortic Stenosis

        13.3.2. Mitral Stenosis

        13.3.3. Tricuspid Stenosis

        13.3.4. Pulmonary Stenosis

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Specialty Clinics

        13.4.3. Ambulatory Surgical Centers

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Transcatheter Valve Repair System Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value & Volume Forecast, by Product, 2017–2031

        14.2.1. Transcatheter Aortic Valve Replacement (TAVR)

        14.2.2. Transcatheter Mitral Valve Replacement (TMVR)

        14.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)

        14.2.4. Transcatheter Tricuspid Valve Replacement (TTVR)

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Aortic Stenosis

        14.3.2. Mitral Stenosis

        14.3.3. Tricuspid Stenosis

        14.3.4. Pulmonary Stenosis

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Specialty Clinics

        14.4.3. Ambulatory Surgical Centers

        14.4.4. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. Abbott Laboratories

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Product Portfolio

            15.3.1.3. Financial Overview

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. Biotronik Pvt. Ltd.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. Financial Overview

            15.3.2.4. SWOT Analysis

            15.3.2.5. Strategic Overview

        15.3.3. Colibri Heart Valve

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Product Portfolio

            15.3.3.3. Financial Overview

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. Edwards Lifesciences Corporation

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Product Portfolio

            15.3.4.3. Financial Overview

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. HLT Medical

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Product Portfolio

            15.3.5.3. Financial Overview

            15.3.5.4. SWOT Analysis

        15.3.6. LivaNova Plc

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Product Portfolio

            15.3.6.3. Financial Overview

            15.3.6.4. SWOT Analysis

        15.3.7. Medtronic plc

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Product Portfolio

            15.3.7.3. Financial Overview

            15.3.7.4. SWOT Analysis

        15.3.8. Neovasc Inc

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. Financial Overview

            15.3.8.4. SWOT Analysis

        15.3.9. Coramaze Technologies

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. Financial Overview

            15.3.9.4. SWOT Analysis

List of Tables

Table 01: Global Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Transcatheter Valve Repair System Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Transcatheter Valve Repair System Market Value Share, by Product (2022)

Figure 03: Global Transcatheter Valve Repair System Market Value Share, by End-user (2022)

Figure 04: Global Transcatheter Valve Repair System Market Value Share, by Application (2022)

Figure 05: Global Transcatheter Valve Repair System Market Value Share, by Region (2022)

Figure 06: Global Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 07: Global Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 08: Global Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 09: Global Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 10: Global Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 11: Global Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 12: Global Transcatheter Valve Repair System Market Value Share Analysis, by Region, 2022 and 2031

Figure 13: Global Transcatheter Valve Repair System Market Attractiveness, by Region, 2022-2031

Figure 14: North America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 15: North America Transcatheter Valve Repair System Market Value Share (%), by Country, 2022 and 2031

Figure 16: North America Transcatheter Valve Repair System Market Attractiveness, by Country, 2023–2031

Figure 17: North America Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 18: North America Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 19: North America Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 20: North America Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 21: North America Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 22: North America Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 23: Europe Transcatheter Valve Repair System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 24: Europe Transcatheter Valve Repair System Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 25: Europe Transcatheter Valve Repair System Market Attractiveness, by Country/Sub-region, 2023–2031

Figure 26: Europe Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 27: Europe Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 28: Europe Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 29: Europe Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 30: Europe Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 31: Europe Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 32: Asia Pacific Transcatheter Valve Repair System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 33: Asia Pacific Transcatheter Valve Repair System Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 34: Asia Pacific Transcatheter Valve Repair System Market Attractiveness, by Country/Sub-region, 2023–2031

Figure 35: Asia Pacific Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 36: Asia Pacific Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 37: Asia Pacific Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 38: Asia Pacific Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 39: Asia Pacific Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 40: Asia Pacific Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 41: Latin America Transcatheter Valve Repair System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 42: Latin America Transcatheter Valve Repair System Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 43: Latin America Transcatheter Valve Repair System Market Attractiveness, by Country/Sub-region, 2023–2031

Figure 44: Latin America Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 45: Latin America Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 46: Latin America Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 47: Latin America Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 48: Latin America Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 49: Latin America Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 50: Middle East & Africa Transcatheter Valve Repair System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Middle East & Africa Transcatheter Valve Repair System Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 52: Middle East & Africa Transcatheter Valve Repair System Market Attractiveness, by Country/Sub-region, 2023–2031

Figure 53: Middle East & Africa Transcatheter Valve Repair System Market Value Share Analysis, by Product, 2022 and 2031

Figure 54: Middle East & Africa Transcatheter Valve Repair System Market Attractiveness, by Product, 2023–2031

Figure 55: Middle East & Africa Transcatheter Valve Repair System Market Value Share Analysis, by Application, 2022 and 2031

Figure 56: Middle East & Africa Transcatheter Valve Repair System Market Attractiveness, by Application, 2023–2031

Figure 57: Middle East & Africa Transcatheter Valve Repair System Market Value Share Analysis, by End-user, 2022 and 2031

Figure 58: Middle East & Africa Transcatheter Valve Repair System Market Attractiveness, by End-user, 2023–2031

Figure 59: Global Transcatheter Valve Repair System Market Share Analysis, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved